Home › Small Cell Lung Cancer › Minnesota
Small Cell Lung Cancer clinical trials in Minnesota
9 studies for Small Cell Lung Cancer are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Minnesota Oncology - Edina Clinic /ID# 280698, Edina
- Mayo Clinic Hospital Rochester /ID# 279784, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
- Mayo Clinic-Rochester, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06892548Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
- Health Partners Cancer Center at Regions Hospital, Saint Paul
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Aug 21, 2026 · NCT07531095A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
- Minnesota Oncology Hematology, Burnsville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06095505DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
- Mayo Clinic, Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT05882058A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Mayo Clinic Cancer Center, Rochester
- Mayo Clinic, Rochester
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT06131840Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
- Sanford Joe Lueken Cancer Center, Bemidji
- Essentia Health Saint Joseph's Medical Center, Brainerd
- Mercy Hospital, Coon Rapids
- and 13 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT06769126Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 11, 2026 · NCT06681220A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 121, Saint Paul
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT05914116From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.